Bryan Supran
Director/Board Member at ANACOR PHARMACEUTICALS INC
Net worth: 212 553 $ as of 30/04/2024
Bryan Supran active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Director/Board Member | 24/06/2016 | - |
| ARRAY TECHNOLOGIES, INC. | Director/Board Member | 30/07/2019 | - |
| Corporate Officer/Principal | 30/07/2019 | - | |
| HALEON PLC | Director/Board Member | 18/07/2022 | - |
| PFIZER, INC. | General Counsel | 01/04/2016 | - |
Career history of Bryan Supran
Former positions of Bryan Supran
| Companies | Position | Start | End |
|---|---|---|---|
Haleon UK Holdings (No.2) Ltd.
 Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Director/Board Member | 31/07/2019 | 18/07/2022 |
| VIATRIS INC. | Director/Board Member | - | 16/11/2020 |
| MEDIVATION INC | Director/Board Member | 28/09/2016 | - |
Statistics
International
| United States | 6 |
| United Kingdom | 3 |
Operational
| Director/Board Member | 6 |
| Corporate Officer/Principal | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 6 |
| Finance | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| VIATRIS INC. | Health Technology |
| HALEON PLC | Distribution Services |
| PFIZER, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. is an investment holding company. Haleon UK Holdings (No.2) Ltd. is based in Weybridge, UK. Founded in 2019, Haleon UK Holdings (No.2 functions as an investment holding company. | Finance |
- Stock Market
- Insiders
- Bryan Supran
- Experience